Lv3
250 积分 2025-09-12 加入
Comprehensive analysis of adverse events associated with T-cell engagers using the FAERS database
3个月前
已完结
Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
3个月前
已完结
Safety evaluation of tarlatamab: A pharmacovigilance study based on the FAERS database
3个月前
已完结
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
3个月前
已完结
Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
3个月前
已完结
Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
3个月前
已完结
Post-marketing safety surveillance of tarlatamab: a real-world pharmacovigilance study based on the FAERS database
3个月前
已完结
Tarlatamab-induced immune-related adverse events: Real-world pharmacovigilance study using the FAERS database
3个月前
已完结
Post-marketing safety surveillance of tarlatamab: a real-world pharmacovigilance study based on the FAERS database
3个月前
已完结
Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system
3个月前
已完结
皖公网安备34019202002308
